Rite Aid Approved to Sell Elixir Business for $575 Million
Briefly

MedImpact, also a pharmacy-benefit management company, had been the stalking horse bidder for Elixir when Rite Aid filed for bankruptcy in October.
Rite Aid conducted an auction process in bankruptcy, but it didn't yield higher or better bids.
Read at WSJ
[
add
]
[
|
|
]